首页 正文

Tyrosine kinase inhibitors in advanced NSCLC: A case report

{{output}}
Erlotinib is a molecule that selectively inhibits epidermal growth factor receptor (EGFR) tyrosine kinase activity. The authors present a case that exemplifies the use of erlotinib as second line therapy for non-small cell lung cancer (NSCLC). This case is abo... ...